fullerene c60 has been researched along with Neuroblastoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Li, M; Li, Q; Mo, J | 1 |
Chen, T; Guan, WC; Li, YY; Lin, Y; Wang, CX; Wang, YJ; Xu, B; Xu, SQ; Zhang, JL | 1 |
Igisu, H; Sumizawa, T | 1 |
Ehrich, M; Kepley, CL; Li, Y; Van Tassell, R; Zhou, Z | 1 |
4 other study(ies) available for fullerene c60 and Neuroblastoma
Article | Year |
---|---|
Calixarene-mediated assembly of water-soluble C
Topics: Antineoplastic Agents; Calixarenes; Cell Line, Tumor; Fullerenes; Graphite; Humans; Lasers; Molecular Conformation; Nanotubes, Carbon; Neuroblastoma; Phosphorous Acids; Photochemotherapy; Reactive Oxygen Species; Solubility; Surface Properties; Water | 2020 |
Protective effect of C(60) -methionine derivate on lead-exposed human SH-SY5Y neuroblastoma cells.
Topics: Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Damage; Fullerenes; Glutathione; Humans; Lipid Peroxidation; Malondialdehyde; Methionine; Neuroblastoma; Neuroprotective Agents; Organometallic Compounds; Oxidative Stress | 2011 |
Suppression of acrylamide toxicity by carboxyfullerene in human neuroblastoma cells in vitro.
Topics: Acrylamide; Antineoplastic Agents; Buthionine Sulfoximine; Carboxylic Acids; Caspase 3; Cell Line, Tumor; Cell Survival; Cytoprotection; Dose-Response Relationship, Drug; Fullerenes; G1 Phase; Glutathione; Humans; L-Lactate Dehydrogenase; Nanoparticles; Neuroblastoma; Neurons; Particle Size | 2009 |
Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
Topics: Acetylcholinesterase; Animals; Antioxidants; Brain; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chickens; Cholinesterase Inhibitors; Cholinesterase Reactivators; Embryo, Mammalian; Fullerenes; Humans; Isoflurophate; Mice; Neuroblastoma; Neurons; Organophosphates; Paraoxon; Superoxides | 2011 |